InFocus: Life Sciences & Healthcare newsletter - February 2008

07-Feb-2008  |  Life Sciences & Healthcare
 


Key issues in February 2008's edition:

  • How the new EFPIA codes will affect pharmaceutical companies in 2008
  • Appealing non-binding patent opinions of the UK IPO
  • The new CRO mCTA introduced by the DOH in October 2007
  • The HFEA's recent approval of research creating hybrid chimeras
  • The new CGT regime - UK Treasury amends proposal
  • Borderline products and the Advanced Therapy Regulation
  • The European Commission's investigation of the pharmaceutical sector

About Taylor Wessing's Life Sciences & Healthcare Group

Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service.  The Group combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices.  We advise life sciences and healthcare businesses, those who fund them and those who work for them.

For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.

For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing.  For any marketing and business development enquiries, please contact Sharon Philbey.

Download the complete article (PDF, 469KB)